Form 8-K Benitec Biopharma Inc. For: Sep 10

Go back to Form 8-K Benitec Biopharma Inc. For: Sep 10

Benitec Biopharma to restate quarterly financial statements

September 12, 2025 4:47 PM EDT

Benitec Biopharma (NASDAQ: BNTC) announced that its audit committee determined the company's quarterly financial statements for periods ended December 31, 2024, and March 31, 2025, should no longer be relied upon due to errors in share-based compensation calculations.

The errors stemmed from the incorrect configuration of a new... More